Arterra Bioscience
ARBS
Rank in Stocks
#26023
Arterra Bioscience S.p.A. is a biotechnology company fundamentally driven by... Arterra Bioscience S.p.A. is a biotechnology company fundamentally driven by scientific research, concentrating on the discovery and development of a wide range of ingredients and nature-based solutions. The firm's activities encompass the creation of advanced technological frameworks, innovative extraction methodologies, and foundational raw materials, specifically tailored for the beauty, agricultural, and nutritional supplement sectors. Established in 2003, Arterra Bioscience S.p.A. is headquartered in Naples, Italy.
Share Price
$3.37
Last synced: 2026-11-11
Market Cap
$22.46M
Change (1 day)
-2.12%
Change (1 year)
-5.53%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Arterra Bioscience (ARBS)
Category
Healthcare
Operating Margin for Arterra Bioscience (ARBS)
Operating Margin as of November 2026 TTM: 10.39%
According to Arterra Bioscience's latest financial reports, its current operating margin (TTM) is 10.39%. At the end of 2025 the company had an operating margin of 12.73%.
Operating Margin history for Arterra Bioscience from 2017 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 10.39% | -18.38% |
| 2025 | 12.73% | -63.82% |
| 2024 | 35.19% | -429.19% |
| 2023 | -10.69% | -205.22% |
| 2022 | 10.16% | -74.89% |
| 2021 | 40.47% | -862.15% |
| 2020 | -5.31% | -201.92% |
| 2019 | 5.21% | -75.21% |
| 2018 | 21.02% | 11.22% |
| 2017 | 18.90% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -96.29% |
US
|
|
| -149.01% | -114.34% |
US
|
|
| 25.57% | -97.54% |
AU
|
|
| 31.23% | -96.99% |
BE
|
|
| 29.35% | -97.18% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Arterra Bioscience's operating margin
What is Arterra Bioscience's operating margin?
Arterra Bioscience's operating margin is 10.39%, as of Nov 2026.
What was Arterra Bioscience's operating margin in 2025?
In 2025, Arterra Bioscience's operating margin was 12.73%, compared with 35.19% in 2024.
How has Arterra Bioscience's operating margin changed since 2020?
From 2020 to 2025, Arterra Bioscience's operating margin was highest in 2021 (40.47%) and lowest in 2023 (-10.69%).
How does Arterra Bioscience's operating margin compare with similar companies?
Arterra Bioscience's operating margin (10.39%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.